单中心8年节段性动脉中膜溶解管理经验
单中心回顾性分析2011至2019年放射学诊断的节段性动脉中膜溶解(SAM)患者30例,27例行非手术治疗,3例行手术干预。手术患者更常见疼痛超过30天(P<0.05)和出血(P<0.01)。非手术治疗包括降压、抗血小板和降脂治疗,27例中6例影像学病变消退,平均消退时间325.5天。
要点
- SAM罕见,无既定治疗或监测指南,干预取决于临床表现。
- 手术干预患者表现为肠系膜缺血或假性动脉瘤破裂。
- 无上述情况者,降压、抗血小板和降脂药物治疗有效。
核心结论
- 接受手术干预的SAM患者表现为肠系膜缺血或假性动脉瘤破裂。
- 无上述情况的患者,由降压药、抗血小板药和降脂治疗组成的药物治疗有效。
- 非手术治疗使所有患者症状缓解,27例中6例在不到一年内影像学异常消退。
研究设计与样本
- 单中心回顾性研究,纳入2011年至2019年放射学诊断的SAM患者30例。
- 比较需手术干预与非手术治疗患者的人口学、围手术期因素及药物治疗策略。
主要发现
- 30例患者中21例(70%)为男性,平均年龄53.5岁(范围35.7-72.2岁)。
- 27例非手术治疗,3例需手术干预;手术患者更常见疼痛超过30天(P<0.05)和出血(P<0.01)。
- 腹痛最常见(n=24,80%),动脉夹层为最常见影像学表现(n=20,67%)。
- 腹腔动脉及其分支最常受累(n=22,73%),其次为肠系膜上动脉及其分支(n=15,50%)。
- 非手术治疗最常用抗高血压治疗(n=13,43%)、抗血小板药(n=17,57%)和降脂药(n=13,43%),7例接受全部三种治疗;6例确认病变消退,平均消退时间325.5天。
临床怎么用
- 对于无肠系膜缺血或假性动脉瘤破裂的SAM患者,原文结论认为由抗高血压药、抗血小板药和降脂治疗组成的药物治疗有效。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Segmental Arterial Mediolysis (SAM) is a rare, poorly understood vasculopathy that involves vacuolization of the arterial wall, most commonly of the visceral arteries. There are no established therapeutic or monitoring guidelines for SAM, and intervention typically depends on patient presentation. The purpose of this study is to review the management and outcomes of patients with this rare vascular disease METHODS: Single center retrospective review of patients diagnosed with SAM between 2011 and 2019. Included were patients with radiological diagnosis of SAM. Demographic factors, past medical history, presenting symptoms, affected vessels, management, and lesion characteristics over time were collected. Demographic and periprocedural factors, and medical management strategies were compared for those who required operative intervention versus those managed non-operatively. RESULTS: Thirty patients were included, 21 (70%) were male, mean age was 53.5 years (range: 35.7-72.2). Twenty-seven patients were managed non-operatively, 3 patients required surgical intervention. Patients who underwent operative intervention were more likely to present with pain >30 days (P < 0.05), and hemorrhage (P < 0.01). Abdominal pain was the most common presenting symptom (n = 24, 80%). Arterial dissection was the most common radiological finding at time of presentation (n = 20, 67%). The celiac artery and its branches were most often involved (n=22, 73%) followed by the superior mesenteric artery and its branches (n = 15, 50%). Non-operative management most often consisted of anti-hypertensive therapy (n = 13, 43%), antiplatelet agents (n = 17, 57%%), and lipid-lowering agents (n = 13, 43%), with 7 patients receiving all three. Six patients demonstrated confirmed resolution of lesions during surveillance imaging, with average time to resolution of 325.5 days. CONCLUSIONS: Patients who underwent intervention for SAM presented with either mesenteric ischemia or pseudoaneurysm rupture. In patients that present without those conditions, medical management consisting of anti-hypertensives, antiplatelet agents, and lipid-lowering therapy was effective. Non operative management resulted in symptom resolution in all patients and surveillance imaging showed resolution of radiographic abnormalities in 6 patients out of 27 at less than one year.
引用
- Srinivasan A, Olowofela A, Rothstein A, et al. A Single Center 8 Year Experience of Segmental Arterial Mediolysis Management. Ann Vasc Surg. 2021. PMID: 34775009. doi:10.1016/j.avsg.2021.09.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。